A new approach to monitoring injection data collected by easypod™ auto-injector in patients receiving a growth hormone treatment with Saizen® Merck Serono, a division of Merck KGaA, Darmstadt, Germany ...
The growth hormone therapy market had become crowded and static. With little variety in the efficacy of drugs or treatments on offer, Merck Serono wanted to develop a device that would achieve ...
In 2003 Merck Serono, a world leader in the field of biotechnology engaged PDD to design an auto-injector for its Growth Hormone (GH) therapy product Saizen®. In what was a saturated and static market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results